Delivery Order SPE2DB20D9103-SPE2DB22FE7F3

Award Date 8/24/22
Potential Completion Date 9/15/22
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $11,101.68, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,567,994,800 units of Botox 100 unit vials, with a completion date of April 23, 2025. The award is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to...
This federal contract award, valued at $11,101.68, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4,567,937,906 units of Botox 100 unit vials, with a completion date of May 2, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $44,087.00 firm fixed-price delivery order for the supply of 4,555,937,918 units of Botox 100 unit vials. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to...
This federal contract award, valued at $10,152.56, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a...
This federal contract award valued at $76,100.40 was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for 4,559,105,286 units of BOTOX 200 UNIT VIALS, with a performance period ending on December 2, 2022. It is a firm fixed-price contract, and there is no set-aside designation mentioned. DMS Pharmaceutical Group Inc. holds a $499,999,999...
This federal contract award, valued at $6,922.20, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order for the supply of 4,565,890,947 units of BOTOX 100 UNIT VIALS. This contract has no set-aside designation and is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award, valued at $13,844.40, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for 4,564,828,313 units of Botox 100 unit vials, with a period of performance through June 27, 2024. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $9,251.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is to provide 4,567,552,642 units of BOTOX 100 UNIT VIALS to support the medical supply needs of military healthcare facilities. This delivery order is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group...
This federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency, by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order awarded under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999, which enables the DLA to issue delivery orders for a comprehensive range of...
This federal contract award, valued at $4,614.80, was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical supplier based in Park Ridge, Illinois. The contract is for the delivery of BOTOX 100 unit vials, with an ultimate completion date of April 22, 2024. This award appears to be a delivery order issued under a larger indefinite delivery vehicle (IDV) contract, contract # SPE2DB, that DMS Pharmaceutical...
  • SPE2DB20D9103
    Indefinite Delivery Contract
  • SPE2DB20D9103-SPE2DB22FE7F3
    Delivery Order

This federal contract award, valued at $5,277.96, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order under the DLA's SPE2DB Indefinite Delivery Contract (IDC), which has a ceiling value of $499,999,999 and is valid through November 2026.

The delivery order is for 4,558,277,483 units of Botox 100 unit vials. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides a diverse array of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. This contract award does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains.

Generated 2/27/25, 11:09 AM